From Monoamine Oxidase Inhibition to Antiproliferative Activity: New Biological Perspectives for Polyamine Analogs

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Oncology

Background:

• Monoamine oxidases (MAOs) are established drug targets for neurological disorders.
• Recent research highlights MAO overexpression in cancers like glioblastoma and prostate cancer.
• This suggests MAO inhibitors could be effective antiproliferative agents.

Purpose of the Study:

• To synthesize and evaluate novel polyamine analogs as inhibitors of human MAOs.
• To investigate the impact of constrained linkers on MAO inhibitory potency.
• To assess the antiproliferative activity of these analogs against glioblastoma cells.

Main Methods:

• Synthesis of a small library of polyamine analogs (compounds 2-7).
• Evaluation of MAO inhibitory potency and mechanism (reversible, competitive).
• Assessment of antiproliferative activity using the LN-229 human glioblastoma cell line.

Main Results:

• Compounds 4 (dianiline) and 5 (dianilide) were identified as the most potent MAO inhibitors (Ki < 1 μM).
• These compounds exhibited reversible and predominantly competitive inhibition.
• Compounds 4 and 5 showed significant antiproliferative effects in glioblastoma cells (GI50 < 1 μM).

Conclusions:

• The polyamine scaffold can be modified to yield potent MAO inhibitors.
• Compounds 4 and 5 demonstrate dual MAO inhibitory and antiproliferative properties.
• Compound 5's scaffold is a promising starting point for developing novel anticancer drugs targeting MAOs.